Pain and Addiction: A Challenging Co-occuring Disorder

Pain and Addiction: A Challenging Co-occuring Disorder

On-Demand Webcast
FACULTY

Mel Pohl, MD, DFASAM
Chief Medical Officer, Las Vegas Recovery Center

PROVIDER STATEMENT

Provided by North American Center for Continuing Medical Education, LLC, an HMP Company.

For questions regarding this educational activity, please call 609-371-1137 or email info@naccme.com.

 

INTENDED LEARNERS

This activity is designed for physicians, pharmacists, advanced practice registered nurses, registered nurses, social workers, addiction professionals, prevention professionals, health education specialists and psychologists.

lEARNING OBJECTIVES

After participating in this activity, participants should be better able to:

  • Describe principles of chronic pain, including central nervous system processing and the brain’s response to pain and suffering.
  • Identify the effects of emotional distress on increasing chronic pain.
  • Discuss techniques to manage opioid dependence and the experience of recovery from chronic pain with clinical methods including mindfulness, CBT, DBT and ACT.
claiming crediT

To be eligible for credit, participants must complete the online activity, a post-test assessment with a score of 70% or better, and the evaluation by September 30, 2020. Upon completing the activity, there will be instructions on how to print a certificate or other documentation of credit.

Release Date: September 30, 2019
Expiration Date: September 30, 2020
Estimated Time to Complete: 1.25 hours

There is no fee associated with this activity.

CONTINUING EDUCATION

    In support of improving patient care, NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIANS

NACCME designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

nursing

This continuing nursing education activity awards 1.25 contact hours.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.25 contact hours. 

PHYSICIAN ASSISTANTS

NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 credit(s). PAs should only claim credit commensurate with the extent of their participation.

PSYCHOLOGISTS

As a Jointly Accredited Organization, North American Center for Continuing Medical Education, LLC (NACCME) is approved by the American Psychological Association to sponsor continuing education for psychologists. NACCME maintains responsibility for this program and its content. Variable credit for partial attendance may not be awarded. Full attendance is required for all CE activities.

 Instructional Level: Advanced

This activity will award 1.25 continuing education credits.

SOCIAL WORK (ASWB ACE)

NACCME is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. NACCME maintains responsibility for this course. Social workers completing this course receive 1.25 Intermediate continuing education credits.

ADDICTION COUNSELORS

This course has been approved by NACCME, LLC, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #182840.  NACCME is responsible for all aspects of the programming.

HEALTH CARE PROVIDERS (AAHCPAD)

The sponsor of this program, North American Center for Continuing Medical Education, LLC has been approved to provide continuing education credit for certified addiction specialists (CAS), approval number No. 19 -1415.

USE OF PROPRIETARY NAMES

This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.

UNAPPROVED AND/OR INVESTIGATIONAL USES OF DRUGS AND DEVICES

This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of NACCME.

DISCLAIMERS

The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.

Neither NACCME nor any of its subsidiaries or affiliates is affiliated with, or formally endorsed by a medical society.

The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME or HMP. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

NACCME, LLC is an independent provider(s) of continuing medical education. NACCME, LLC has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.

NACCME, LLC assures that all educational materials are reviewed to ensure for the absence of commercial bias, fair balance, scientific objectivity, and levels of evidence. The educational activity will not be influenced by commercial organizations and will not conflict with any other scheduled educational activities.

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

Planning Committee

The planning committee comprises Louis E. Baxter, Sr., MD, DFASAM, DABAM, President and CEO of the Professional Assistance Program of New Jersey, Inc.; Carol Boyer, National Director of Community and Government Partnerships Delphi Behavioral Health Group Company; Mary P. Hauser, MA, Vice President of Addiction Services and New Market Development; J. Gregory Hobelmann, MD, MPH, Chief Medical Officer, Ashley Treatment; Mary Jo Mather, Executive Director of the International Certification & Reciprocity Consortium, Inc. (IC&RC); Philip T. McCabe, CSW, CAS, CDVC, DRCC, Health Educator at Rutgers School of Public Health, President of NALGAP: The Association of Lesbian, Gay, Bisexual, Transgender, Addiction Professionals and their Allies; Zach Snitzer, Co-Founder and Director of Business Development, Maryland Addiction Recovery Center; and Mary Ryan Woods, RNC, LADC, MSHS, CEO Mary Ryan Woods Consulting.

NACCME planners and staff include Kristin Ciszeski, Raquel Gaerlan, Chris Bolwell, Jennifer Ilcyn, Nimma Ovwori, Doug Edwards, Horacio Rodriguez, and Randy Robbin.

Chris Bolwell is a shareholder of GlaxoSmithKline. GlaxoSmithKline is not supporting this activity, nor does any content relate to their product/service

Faculty
The faculty has reported the following:

Mr. Pohl has disclosed no relevant financial relationships with any commercial interests.

ADA STATEMENT

North American Center for Continuing Medical Education (NACCME) complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.

PRIVACY POLICY

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint providers. NACCME and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2019 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.